Haemorrhagic events in patients with transthyretin cardiac amyloidosis

Key Points

• Bleeding complications are common in patients with transthyretin cardiac amyloidosis and are linked to higher HAS-BLED scores.
• A HAS-BLED score of 2 or higher significantly increases the risk of haemorrhagic events in affected individuals.
• Analysis indicates that anticoagulation use further elevates the risk of bleeding in this patient population.
• These findings may inform risk stratification and therapeutic decisions for managing transthyretin cardiac amyloidosis.

Abstract